Victory Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Victory Capital Management's ASND Position: Q3 2026 in Review
Victory Capital Management increased its Ascendis Pharma (ASND) stake by 20% in Q3 2026, buying an estimated $1.36M and bringing the position to 32,912 shares worth $7.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1245.
Victory Capital Management first reported a position in ASND in Q1 2017 and has held it in 27 quarters since. The position peaked at $84.7M in Q4 2020. 346 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Victory Capital Management held 32,912 shares of Ascendis Pharma worth $7.5M as of Q3 2026.
- Victory Capital Management bought 5,372 Ascendis Pharma shares in Q3 2026, an estimated $1.36M.
- Ascendis Pharma made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1245 holding.
- Victory Capital Management first reported a position in Ascendis Pharma in Q1 2017 and has held it in 27 quarters since.
- Victory Capital Management's Ascendis Pharma position peaked at $84.7M in Q4 2020.
- 346 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.